Summary
18.50 -0.69(-3.60%)09/06/2024
Medifast Inc (MED)
Medifast Inc (MED)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
-3.62 | 1.09 | -8.75 | -15.33 | -51.44 | -76.54 | -77.95 | 344.71 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Trading Data | ||
Close | 18.50 | |
Open | 19.26 | |
High | 19.95 | |
Low | 18.47 | |
Volume | 207,218 | |
Change | -0.70 | |
Change % | -3.62 | |
Avg Volume (20 Days) | 212,713 | |
Volume/Avg Volume (20 Days) Ratio | 0.97 | |
52 Week Range | 17.74 - 83.60 | |
Price vs 52 Week High | -77.87% | |
Price vs 52 Week Low | 4.28% | |
Range | -3.95 | |
Gap Up/Down | -0.38 |
Fundamentals | ||
Market Capitalization (Mln) | 202 | |
EBIDTA | 95,525,000 | |
PE Ratio | 4.0372 | |
PEG Ratio | 1.9500 | |
WallStreet Target Price | 25.00 | |
Book Value | 19.7250 | |
Earnings Per Share | 6.1900 | |
EPS Estimate Current Quarter | 0.7800 | |
EPS Estimate Next Quarter | 0.6700 | |
EPS Estimate Current Year | 0.7600 | |
EPS Estimate Next Year | 1.8900 | |
Diluted EPS (TTM) | 6.1900 | |
Revenues | ||
Profit Marging | 0.0755 | |
Operating Marging (TTM) | 0.0529 | |
Return on asset (TTM) | 0.1644 | |
Return on equity (TTM) | 0.3549 | |
Revenue TTM | 897,809,984 | |
Revenue per share TTM | 82.4040 | |
Quarterly Revenue Growth (YOY) | -0.4990 | |
Quarterly Earnings Growth (YOY) | -0.7930 | |
Gross Profit (TTM) | 1,140,414,000 |
Dividends | ||
Dividend Share | 3.3000 | |
Dividend Yield | 0.2641 | |
Valuations | ||
Trailing PE | 4.0372 | |
Forward PE | 0.0000 | |
Price Sales (TTM) | 0.0000 | |
Price Book (MRQ) | 1.7040 | |
Revenue Enterprise Value | 0.2008 | |
EBITDA Enterprise Value | 1.5432 | |
Shares | ||
Shares Outstanding | 10,937,200 | |
Shares Float | 9,714,812 | |
Shares Short | 0 | |
Shares Short (Prior Month) | 0 | |
Shares Ratio | 0.00 | |
Short Outstanding (%) | 0.00 | |
Short Float (%) | 0.43 | |
Insider (%) | 2.69 | |
Institutions (%) | 91.54 |
09/07 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Whether Medifast Inc Violated Securities Laws And Investors Can Partake In The Investigation
LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Whether Medifast Inc Violated Securities Laws And Investors Can Partake In The Investigation
LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/06 11:00 EST - accesswire.com
Stakeholders With Losses In Medifast, Inc. Are Urged By The Schall Law Firm To Reach Out About An Inquiry Into Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Stakeholders With Losses In Medifast, Inc. Are Urged By The Schall Law Firm To Reach Out About An Inquiry Into Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/05 11:00 EST - accesswire.com
Medifast Inc Might Have Committed Securities Fraud And Investors Should Join The Schall Law Firm's Investigation
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast Inc Might Have Committed Securities Fraud And Investors Should Join The Schall Law Firm's Investigation
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/04 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Laws And Impacted Shareholders Can Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Laws And Impacted Shareholders Can Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/03 11:00 EST - accesswire.com
Investors With Losses In Medifast Inc Are Encouraged To Help The Schall Law Firm In A Securities Fraud Investigation
LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Investors With Losses In Medifast Inc Are Encouraged To Help The Schall Law Firm In A Securities Fraud Investigation
LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/02 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Regulations And The Public Is Invited To Join
LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Regulations And The Public Is Invited To Join
LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/01 11:00 EST - accesswire.com
Medifast Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Seeks Shareholder Participation
LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Seeks Shareholder Participation
LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/31 11:00 EST - accesswire.com
An Inquiry By The Schall Law Firm Has Been Launched Into Medifast Inc. For Violating Securities Regulations And Affected Investors Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
An Inquiry By The Schall Law Firm Has Been Launched Into Medifast Inc. For Violating Securities Regulations And Affected Investors Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/30 11:00 EST - accesswire.com
Medifast Inc Is Being Looked Into For Securities Fraud And The Schall Law Firm Urges Individuals With Losses To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast Inc Is Being Looked Into For Securities Fraud And The Schall Law Firm Urges Individuals With Losses To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/29 11:00 EST - accesswire.com
The Schall Law Firm Has Launched An Inquiry Into Medifast Inc. For Violating Securities Regulations And Investors Can Take Part
LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Has Launched An Inquiry Into Medifast Inc. For Violating Securities Regulations And Investors Can Take Part
LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/29 07:25 EST - accesswire.com
Medifast Being Investigated on Behalf of Medifast, Inc. Investors. Contact Levi & Korsinsky For Details
NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
Medifast Being Investigated on Behalf of Medifast, Inc. Investors. Contact Levi & Korsinsky For Details
NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
08/28 11:00 EST - accesswire.com
Medifast Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/28 07:40 EST - accesswire.com
Medifast, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - MED
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
Medifast, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - MED
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
08/27 11:00 EST - accesswire.com
Investors Are Invited By The Schall Law Firm To Participate In An Inquiry Into Medifast Inc For Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Investors Are Invited By The Schall Law Firm To Participate In An Inquiry Into Medifast Inc For Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/27 07:45 EST - accesswire.com
Levi & Korsinsky Announces an Investigation on Behalf of Medifast, Inc. (MED) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
Levi & Korsinsky Announces an Investigation on Behalf of Medifast, Inc. (MED) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
08/26 11:05 EST - zacks.com
Medifast's (MED) Strategies Aid Amid Evolving Market Demands
Medifast (MED) is making efforts to thrive in the rapidly evolving weight loss market, as the adoption of GLP-1 medications reshapes industry dynamics.
Medifast's (MED) Strategies Aid Amid Evolving Market Demands
Medifast (MED) is making efforts to thrive in the rapidly evolving weight loss market, as the adoption of GLP-1 medications reshapes industry dynamics.
08/26 11:00 EST - accesswire.com
Medifast Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders To Join
LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders To Join
LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/25 12:17 EST - accesswire.com
An Investigation Has Commenced on Behalf of Medifast, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your MED Losses.
NEW YORK, NY / ACCESSWIRE / August 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
An Investigation Has Commenced on Behalf of Medifast, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your MED Losses.
NEW YORK, NY / ACCESSWIRE / August 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
08/25 11:00 EST - accesswire.com
The Schall Law Firm Has Launched An Inquiry Into Medifast Inc And The Firm Is Seeking Investors To Participate
LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Has Launched An Inquiry Into Medifast Inc And The Firm Is Seeking Investors To Participate
LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/24 21:01 EST - accesswire.com
MED ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Medifast, Inc. investment
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
MED ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Medifast, Inc. investment
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.